Related Experiment Video
Updated: May 15, 2026

Continuous Theta Burst Stimulation of the Posterior Medial Frontal Cortex to Experimentally Reduce Ideological Threat Responses
Published on: September 28, 2018
Neuromodulation in the service of moral enhancement
1Institute for Biomedical Ethics, University of Geneva, Geneva, Switzerland, Bernard.Baertschi@unige.ch.
Abstract:
Human enhancement is a much debated topic in the bioethical literature. Human beings have long tried to improve their capacities and their performances through training and with the aid of tools; but more recently new means have come to the fore, such as drugs and biotechnological devices, especially in the domain of bodily strength and cognitive powers. Moral enhancement has been more seldom discussed. However, this question has recently been hotly debated between two philosophers, Thomas Douglas and John Harris. Douglas claims that modulating certain ugly emotions directly would consist in moral progress-directly, that is, without using cognitive means like persuasion or deliberation. Harris makes three objections against this thesis: such a direct neuromodulation would be inefficacious, would put our liberty in jeopardy and would lead to a moral decline. In this paper, I examine the third argument: with direct modulation, we risk intervening too much or too little, inducing an inappropriate emotion or an inappropriate level of an otherwise appropriate emotion-two upshots that will put morality in jeopardy. I conclude that the validity of this objection depends on several meta-ethical positions: if you are a rationalist or think that intentionality and consciousness are at the core of morality, you will agree with Harris, but if you are a sentimentalist or someone for whom results count, you will disagree. Here as elsewhere, ethical questions cannot be divorced from meta-ethical ones.
Related Concept Videos
Neural Regulation
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Long-term Potentiation
Hebbian LTP
LTP can occur when presynaptic neurons...
Egoism and Altruism
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Motor Unit Stimulation
The latent period of contraction marks the onset of excitation-contraction coupling, when the action potential propagates across the sarcolemma, preparing the muscle fibers for contraction. As the fibers enter the contraction phase, the...

